Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when a pandemic springs up as fast as the one sparked by […]
New “Diabetic Fiber” Captures Attention of Diabetics Nationwide
Palm Beach, FL – April 8, 2020 – A new “diabetic” nutritional fiber recognized by the Food & Drug Administration (FDA) and shown in clinical data to slow the body’s absorption of sugar and improve overall blood sugar levels is just now finding its way into products catering to America’s millions of diabetics – and […]
Moleculin Announces Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100%
Independent research shows 2-DG activity against virus that causes COVID-19 Houston, TX – April 8, 2020 – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that independent research found 2-deoxy-D-glucose (“2-DG”) to reduce replication of SARS-CoV-2, the virus that […]
